Stop scrolling.
Start investing.
Stock Pixie cuts through the noise
to curate quality stocks on sale.Back the missions you believe in.
Invest in the research that matters to you.
7-day free trial. Cancel anytime.
Today's Top Pick
--FCF Yield
--P/E
--52w Drawdown
Stock Pixie Covers
ESG and social impact scoring
Environmental, social, and governance data alongside fundamentals.
Biotech clinical pipeline analysis
Cash runway, trial phase, and disease-area context so you can assess risk before the headline.
Biotech investing guide →Investing guides for every level
Plain-English explanations of the metrics and strategies behind every screen.
Browse all guides →Dividend and income analysis
Yield sustainability, payout coverage, and free cash flow discipline surfaced alongside fundamentals.
Dividend investing guide →Fundamental value screening
P/E, FCF yield, margin of safety, and drawdown compared against sector medians.
Value investing guide →Growth stage risk modeling
Cash runway and dilution discipline for pre-profit companies building toward profitability.
Reading stock metrics →Stock Pixie Gives You an Unfair Advantage.
Most traders chase hype. Stock Pixie tracks value and helps you see how each company touches the world, so your picks line up with the missions you care about.
How most investors pick stocks
How Stock Pixie helps you choose
Panic selling during the dip
Buying the dip
Impact and purpose as a vibe, not a clear picture
Environmental and social good impact pillars plus company values next to fundamentals, so you see how your capital meets the world
Biotech as a ticker and a headline
Clinical trial progress and disease search so you can back research that matches your priorities
Chasing 52-week highs
Capturing 52-week lows with strong fundamentals
Following analyst upgrades
Screening for P/E below sector median
Buying after a big earnings beat
Flagging stocks trading below intrinsic value
Reacting to short-term volatility
Weighting long-term trend signals
Beyond the screener
Invest with your head and your heart.
Analysis that keeps your values in the picture. Built for investors who want their portfolios to matter.
For the conscious investor
Put your money where your heart is.
Twelve impact dimensions with sourced notes, so you can filter the market by what matters to you.
- Climate & Clean Energy
- Clean Mobility
- Water & Resources
- Health & Healthcare Access
- Financial Inclusion
- Circular Economy
- Sustainable Food & Agriculture
- Education & Access
- Workforce Equity & DEI
- Women's Health & Autonomy
- LGBTQ+ Inclusion
- Community Giving & Philanthropy
For the curious investor
See what a biotech company is actually building.
Search by disease to find every public company in the race, see how far along their trials are, and check their Phase 3 success rate before you invest. Plain-English context throughout, no medical degree required.
Loading a live example…
Start your free trial →For the patient advocate
Invest in the cure.
Start from the disease at the center of your story, then see who is in the race and how far along they are in their research.
A few of the most-researched right now:
- Alzheimer's disease
Live counts in your trial workspace - Type 2 diabetes
Live counts in your trial workspace - Non-small cell lung cancer
Live counts in your trial workspace
Thousands of diseases tracked, from Alzheimer's to rare pediatric cancers.
Start your free trial →You shouldn't have to choose between investing in your future and following your values.
Stock Pixie is built for investors who refuse to compromise.
Subscribers Get Full Access.
Free users have access to 10 of 184 unlocked rows on the Buy the Dip screener. Upgrade to unlock the full list.
| Pixie Rank | Ticker | Company | Score | P/E | 52w Drawdown | Rating |
|---|---|---|---|---|---|---|
| 1 | Hidden | Hidden | 8.9 | 21.3 | -18% | Exciting |
| 2 | Hidden | Hidden | 8.4 | 14.8 | -22% | Exciting |
| 3 | Hidden | Hidden | 8.1 | 22.1 | -19% | Exciting |
| 4 | Hidden | Hidden | 7.8 | 13.2 | -25% | Interesting |
| 5 | Hidden | Hidden | 7.5 | 25.4 | -15% | Interesting |
| 6 | KO | Coca-Cola | 7.2 | 23.7 | -17% | Interesting |
| 7 | T | AT&T Inc | 6.9 | 9.8 | -31% | Interesting |
| 8 | CVX | Chevron Corp | 6.5 | 15.1 | -28% | Interesting |
| 9 | ABBV | AbbVie Inc | 6.1 | 18.3 | -20% | Interesting |
| 10 | PFE | Pfizer Inc | 5.8 | 12.1 | -42% | Meh |
Already convinced?Start your free trial
Different securities, different signals.
9 categories of assets, each with its own scoring model.
Buy the Dip
You believe price and value diverge. This finds where they've diverged the most.
Social Good
Fundamentals-first screen for companies scoring well on social and environmental impact.
Utilities
Steady cash flow and dividend discipline. Scored for resilience.
Biotech
Scored for cash runway, dilution, fundamentals, and clinical-trial pipeline momentum.
Dividends
You invest for income. This finds yield that is built to last.
Growth Stage
Companies building toward profitability. Scored on survival, revenue growth, and whether the market is mispricing the story.
Simple pricing.
Start free. Upgrade when you're ready.
Free
$0
Forever free
- Up to 10 rows per screener; top 5 by Pixie rank hide ticker and price
- Emails and landing pages may highlight the top 5 names
- All screeners
- Ticker detail pages
- Blog access
Most popular
Pro
$15
per month, or $135/year (3 months free, 25% off)
- Environmental and Social Good impact news and updates
- Clinical trial readouts and research tools
- Disease finder company search
- Site-wide company/ticker search
- Full access to blog content
- Every row on each screener — no row cap
- Everything in Free
Still not sure?
- Is this just another stock screener?
- Definitely not! Stock Pixie does have screeners for value stocks, dividends, biotech, social impact companies, growth stage, ETFs, and utilities, but each is built differently for each asset class with research tools that let you dive deeper into their unique dimensions. Ticker detail pages add fundamentals, impact breakdowns, and for biotech, clinical trial data that go deeper than other screener tools on the market.
- Does it cover ESG and social impact?
- Yes. The Social Good screener filters for companies in clean energy, water, healthcare access, and financial inclusion, with fundamentals shown right there. Each company also has an impact breakdown: twelve dimensions like labor practices, community investment, and environmental policies, each with sourced notes.
- What can I do with biotech stocks?
- The biotech screener weighs cash runway, dilution, fundamentals, and clinical trial pipeline momentum. Each biotech ticker detail page shows what the company is actually building: trial counts, phases, and the conditions being researched. Or go the other way with the disease finder: start from a condition, and see every public company working on it. No biology degree required.
- How is this different from Yahoo Finance or Finviz?
- Those tools give you data and expect you to know what to do with it. Stock Pixie introduces you to stocks and ETFs via screeners that are tailored to specific lenses: value, income, social impact, biotech, growth, and more. The fundamentals are combined with impact context and clinical trial data, so you don't have to curate, calculate and compare it all by yourself.
- Is the data accurate?
- Financial data is from yfinance and SEC filings. Underlying analysis is built from those figures. Verify anything consequential with primary sources before you act on it.
- Can I cancel anytime?
- Yes. Your access runs through the end of the billing period when you cancel. The free trial is 7 days, no credit card needed.